Genes predict adjuvant trastuzumab outcomes in HER2-positive breast cancerDecember 21, 2012Breast Cancer
'Chemobrain' starts before chemotherapy in breast cancer studyDecember 18, 2012Breast CancerNeuro-oncology
FDA approves ponatinib for CML and Ph-positive ALLDecember 14, 2012Leukemia, Myelodysplasia, Transplantation
Targeting new myeloma pathway pays off with ARRY-520December 13, 2012Lymphoma & Plasma Cell DisordersLeukemia, Myelodysplasia, Transplantation